Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (51-60 of 937) with videos related to

Pageof 94
Sort By:
Nature Reviews. Neurology|January 15, 2014
Neuro-oncology in 2013: improving outcome in newly diagnosed malignant gliomaMichael Weller, Wolfgang Wick
Nature Reviews. Clinical Oncology|March 15, 2019
Immunotherapy for glioblastoma: quo vadis?Michael Weller, Emilie Le Rhun
Therapeutische Umschau. Revue Therapeutique|April 3, 2019
[Update on primary brain tumours]Hans-Georg Wirsching, Michael Weller
Cancer Treatment Reviews|May 15, 2020
How did lomustine become standard of care in recurrent glioblastoma?Michael Weller, Emilie Le Rhun
Journal of Neuro-Oncology|January 28, 2005
Apoptosis in gliomas: molecular mechanisms and therapeutic implicationsJoachim P Steinbach, Michael Weller
Med (New York, N.Y.)|May 19, 2022
Vaccination for IDH-mutant tumors: A novel therapeutic approach applied to gliomaDavid A Reardon, Michael Weller
Trends in Cancer|January 19, 2020
Does Neuronal Activity Promote Glioma Progression?Hans-Georg Wirsching, Michael Weller
Current Treatment Options in Oncology|August 10, 2016
The Role of Molecular Diagnostics in the Management of Patients with GliomasHans-Georg Wirsching, Michael Weller
Journal of Neuro-Oncology|January 28, 2005
Apoptosis in Gliomas: Molecular Mechanisms and Therapeutic ImplicationsJoachim P Steinbach, Michael Weller
The Lancet. Oncology|December 4, 2018
Pseudoprogression: fact or wishful thinking in neuro-oncology?David A Reardon, Michael Weller
Pageof 94

Showing results (51-60 of 937) with videos related to

Sort By:
Pageof 94
Nature Reviews. Neurology|January 15, 2014
Neuro-oncology in 2013: improving outcome in newly diagnosed malignant gliomaMichael Weller, Wolfgang Wick
Nature Reviews. Clinical Oncology|March 15, 2019
Immunotherapy for glioblastoma: quo vadis?Michael Weller, Emilie Le Rhun
Therapeutische Umschau. Revue Therapeutique|April 3, 2019
[Update on primary brain tumours]Hans-Georg Wirsching, Michael Weller
Cancer Treatment Reviews|May 15, 2020
How did lomustine become standard of care in recurrent glioblastoma?Michael Weller, Emilie Le Rhun
Journal of Neuro-Oncology|January 28, 2005
Apoptosis in gliomas: molecular mechanisms and therapeutic implicationsJoachim P Steinbach, Michael Weller
Med (New York, N.Y.)|May 19, 2022
Vaccination for IDH-mutant tumors: A novel therapeutic approach applied to gliomaDavid A Reardon, Michael Weller
Trends in Cancer|January 19, 2020
Does Neuronal Activity Promote Glioma Progression?Hans-Georg Wirsching, Michael Weller
Current Treatment Options in Oncology|August 10, 2016
The Role of Molecular Diagnostics in the Management of Patients with GliomasHans-Georg Wirsching, Michael Weller
Journal of Neuro-Oncology|January 28, 2005
Apoptosis in Gliomas: Molecular Mechanisms and Therapeutic ImplicationsJoachim P Steinbach, Michael Weller
The Lancet. Oncology|December 4, 2018
Pseudoprogression: fact or wishful thinking in neuro-oncology?David A Reardon, Michael Weller
Pageof 94